Progressive Supranuclear Palsy
📧 Sign up to get email alerts when something new happens for Progressive Supranuclear Palsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Diagnosing Frontotemporal Lobar Degeneration
Ongoing University Health Network-sponsored clinical trial aims to improve diagnosis of frontotemporal lobar degeneration across several syn…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Personalized Parkinson Project PSP Cohort
A completed update on the PSP cohort within the Personalized Parkinson Project, led by Radboud University Medical Center, focusing on Progre…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP [Phase 2]
Phase 2 study evaluating tolerability, safety, pharmacokinetics and effect of AZP2006 in progressive supranuclear palsy has completed.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely [NA]
A NeuraLight-sponsored clinical trial is enrolling by invitation to evaluate routine oculometric pattern measurements for distinguishing Par…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Trial of Parkinson's And Zoledronic Acid [Phase 4]
A Phase 4 trial investigating zoledronic acid in patients with Parkinson's disease and osteoporosis is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: NYSCF Scientific Discovery Biobank
Clinical trial entry for the NYSCF Scientific Discovery Biobank (NCT06203106) shows recruiting status and lists indications including amyotr…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Evaluation of [18F]APN-1607 as a PET Biomarker [Phase 1]
Phase 1 trial updates report evaluation of the PET biomarker [18F]APN-1607 in Progressive Supranuclear Palsy and healthy volunteers. The stu…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism [Phase 2]
A Phase 2 randomized, double-blind trial evaluating NAD replenishment therapy for atypical parkinsonism is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: AMX0035 and Progressive Supranuclear Palsy [Phase 2, Phase 3]
AMX0035 is being tested in Phase 2 and Phase 3 trials for progressive supranuclear palsy, with the study currently active but not recruiting…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders [NA]
This entry provides an update on a clinical trial evaluating CUE1 and CUE1+ in people with Parkinson's disease and related disorders; recrui…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes
This ongoing study aims to understand how atypical parkinsonian syndromes affect health-care utilization and quality of life in patients.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: ADDIA Proof-of-Performance Clinical Study
ADDIA Proof-of-Performance clinical study by Amoneta Diagnostics SAS has completed; the update lists multiple neurodegenerative conditions a…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
A clinical trial update evaluating progression markers in neurodegenerative diseases, including Parkinson's disease, currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Biomarkers in Parkinsonian Syndromes
An ongoing clinical trial is recruiting to investigate biomarkers across Parkinsonian syndromes, including Parkinson's disease and Progressi…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
This clinical trial update describes an NMR-based metabolomic study to identify serum biomarkers in patients with Parkinson's disease and at…
-
CLINICAL_TRIALS research · 2024-04-01Clinical Trial Update: In-Home Care for Patients With PSP and Related Disorders [NA]
A completed clinical trial evaluating in-home care for patients with PSP and related disorders, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy [Phase 3]
Phase 3 trial evaluating RIVAstigmine for motor, cognitive, and behavioral impairment in progressive supranuclear palsy has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 [Phase 2]
Phase 2 clinical trial update for a Rho kinase (ROCK) inhibitor being studied in tauopathies.
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA) [Phase 2]
Phase 2 trial of NBMI for atypical Parkinsonian disorders (Progressive Supranuclear Palsy and Multiple System Atrophy) has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY [Phase 2]
Phase 2 clinical trial update for RT001 in progressive supranuclear palsy (PSP).
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP) [Phase 2]
Phase 2 trial of ABBV-8E12 in progressive supranuclear palsy was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP) [Phase 2]
An extension study of ABBV-8E12 in progressive supranuclear palsy (PSP) was terminated after Phase 2; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Study of BIIB092 in Participants With Progressive Supranuclear Palsy [Phase 2]
Phase 2 study of BIIB092 in progressive supranuclear palsy was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers [Phase 1]
Phase 1 trial update on tau imaging in progressive supranuclear palsy and corticobasal degeneration, with healthy volunteers; study complete…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks [Phase 1, Phase 2]
A clinical trial update evaluating tolfenamic acid in individuals with Progressive Supranuclear Palsy across Phase 1 and Phase 2.